[go: up one dir, main page]

AU2001291162A1 - Production of viral vectors - Google Patents

Production of viral vectors

Info

Publication number
AU2001291162A1
AU2001291162A1 AU2001291162A AU9116201A AU2001291162A1 AU 2001291162 A1 AU2001291162 A1 AU 2001291162A1 AU 2001291162 A AU2001291162 A AU 2001291162A AU 9116201 A AU9116201 A AU 9116201A AU 2001291162 A1 AU2001291162 A1 AU 2001291162A1
Authority
AU
Australia
Prior art keywords
production
viral vectors
viral
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291162A
Inventor
Jeffrey S. Chamberlain
Dennis J. Hartigan-O'connor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Michigan System
Original Assignee
University of Michigan System
University of Michigan Ann Arbor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Michigan System, University of Michigan Ann Arbor filed Critical University of Michigan System
Publication of AU2001291162A1 publication Critical patent/AU2001291162A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/38—Vector systems having a special element relevant for transcription being a stuffer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001291162A 2000-09-25 2001-09-21 Production of viral vectors Abandoned AU2001291162A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23506000P 2000-09-25 2000-09-25
US60/235,060 2000-09-25
PCT/US2001/029496 WO2002027007A2 (en) 2000-09-25 2001-09-21 Production of viral vectors

Publications (1)

Publication Number Publication Date
AU2001291162A1 true AU2001291162A1 (en) 2002-04-08

Family

ID=22883933

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291162A Abandoned AU2001291162A1 (en) 2000-09-25 2001-09-21 Production of viral vectors

Country Status (4)

Country Link
US (5) US7820441B2 (en)
EP (2) EP1320620B1 (en)
AU (1) AU2001291162A1 (en)
WO (1) WO2002027007A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820441B2 (en) 2000-09-25 2010-10-26 The Regents Of The University Of Michigan Production of viral vectors
DE10248141B4 (en) * 2002-10-11 2007-04-19 Universitätsklinikum Hamburg-Eppendorf Nucleic acids and their use for gene therapy
ES2337973B8 (en) * 2008-05-16 2011-07-21 Proyecto De Biomedicina Cima, S.L. ADENOVIRUS AUXILIARY SELF-INACTIVANTS FOR THE PRODUCTION OF ADENOVIRUS RECOMBINANTS OF HIGH CAPACITY.
US10221218B2 (en) 2011-05-10 2019-03-05 The Regents Of The University Of California Adenovirus isolated from titi monkeys
WO2012154994A2 (en) * 2011-05-10 2012-11-15 The Regents Of The University Of Californa A novel adenovirus isolated from titi monkeys
TW202333779A (en) 2017-05-08 2023-09-01 美商磨石生物公司 Alphavirus neoantigen vectors
CN118955720A (en) 2018-01-04 2024-11-15 伊科尼克治疗公司 Anti-tissue factor antibodies, antibody-drug conjugates and related methods
US20190315808A1 (en) * 2019-05-07 2019-10-17 Kuopio Center for Gene and Cell Therapy Oy Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
EP3976075A4 (en) 2019-05-30 2023-08-16 Gritstone bio, Inc. MODIFIED ADENOVIRUS
WO2021183717A1 (en) 2020-03-11 2021-09-16 Nantcell, Inc. Proteinaceous therapeutics
IL300026A (en) 2020-08-06 2023-03-01 Gritstone Bio Inc Multiepitope vaccine cassettes
JP2024518553A (en) * 2021-05-13 2024-05-01 フォージ バイオロジクス，インコーポレイテッド Adenovirus helper plasmids
US20240327492A1 (en) 2021-07-29 2024-10-03 Nantcell, Inc. Modified T Cell Receptors For The Prevention And Treatment Of Viral Infections And Cancer
EP4335870A1 (en) 2022-09-06 2024-03-13 NantCell, Inc. Peptide therapeutics against sars-cov-2 spike protein
US20260001951A1 (en) 2024-06-28 2026-01-01 Immunitybio, Inc. Anti-SLAMF7 Antibodies And Therapeutics

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6120764A (en) * 1993-06-24 2000-09-19 Advec, Inc. Adenoviruses for control of gene expression
US6080569A (en) * 1993-06-24 2000-06-27 Merck & Co., Inc. Adenovirus vectors generated from helper viruses and helper-dependent vectors
US5919676A (en) 1993-06-24 1999-07-06 Advec, Inc. Adenoviral vector system comprising Cre-loxP recombination
TW442569B (en) 1993-10-25 2001-06-23 Canji Inc Recombinant adenoviral vector
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6045802A (en) 1994-10-03 2000-04-04 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
US5707618A (en) * 1995-03-24 1998-01-13 Genzyme Corporation Adenovirus vectors for gene therapy
US6156497A (en) 1996-01-05 2000-12-05 Genetic Therapy, Inc. Recombinase-mediated generation of adenoviral vectors
US6630346B1 (en) * 1996-06-20 2003-10-07 Merck & Co., Inc. Gene therapy for obesity
US5994132A (en) 1996-10-23 1999-11-30 University Of Michigan Adenovirus vectors
EP1115880A2 (en) * 1998-09-22 2001-07-18 University of Florida Methods for large-scale production of recombinant aav vectors
CA2344700C (en) 1998-10-01 2005-03-29 Pioneer Hi-Bred International, Inc. Method of plant transformation
AU774076C (en) 1998-12-09 2005-04-14 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The A recombinant vector expressing multiple costimulatory molecules and uses thereof
JP4249832B2 (en) * 1998-12-28 2009-04-08 タカラバイオ株式会社 Trigger factor expression plasmid
WO2000046360A1 (en) * 1999-02-04 2000-08-10 Merck & Co., Inc. Improved helper dependent vector system for gene therapy
US7820441B2 (en) * 2000-09-25 2010-10-26 The Regents Of The University Of Michigan Production of viral vectors
US7410758B2 (en) 2001-07-20 2008-08-12 Board Of Regents, The University Of Texas System Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
US8236776B2 (en) 2002-04-09 2012-08-07 Sanofi Pasteur Limited Modified CEA nucleic acid and expression vectors

Also Published As

Publication number Publication date
WO2002027007A2 (en) 2002-04-04
US20190127758A1 (en) 2019-05-02
US20140193858A1 (en) 2014-07-10
WO2002027007A3 (en) 2003-02-06
EP1320620A2 (en) 2003-06-25
EP2336339A3 (en) 2011-09-14
US10167485B2 (en) 2019-01-01
US20170204431A1 (en) 2017-07-20
EP2336339A2 (en) 2011-06-22
US9453240B2 (en) 2016-09-27
US20110033926A1 (en) 2011-02-10
EP1320620B1 (en) 2015-01-21
US7820441B2 (en) 2010-10-26
US8637313B2 (en) 2014-01-28
US20040087029A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
AU2002223589A1 (en) Production of polypropylene
AUPR464601A0 (en) Shapes vector
AU2002348151A1 (en) Viral vector production methods and compositions
AU2002241793A1 (en) Process for the preparation of organoclays
AU2001291162A1 (en) Production of viral vectors
AU2001232054A1 (en) Vector
AU7739000A (en) Temperature-sensitive regulation of viral vector production
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU2002247848A1 (en) Methods for the production of minicircles
AU2001265935A1 (en) Production of biohydrolysates
AU2002356615A1 (en) Novel utilization of cyclopentabenzofurans
AU2002227035A1 (en) Methods of stabilizing fruit-concentrate powders
AU2001256675A1 (en) Method of preparing virus vector
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU4672401A (en) Vectors
AU7711800A (en) Novel uses of 2-bromopalmitate
AU2002239568A1 (en) Production of alkyl 6-aminocaproate
AU5462901A (en) Process for the preparation of (pyridinylidene)-phthalides
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2000258438A1 (en) An improved process for the preparation of acylferrocenes
AU2000279379A1 (en) An improved process for the preparation of 10h-phenoxazine
AU2000276980A1 (en) Production of concrete
AU6428201A (en) Process for the preparation of 1-substituted-cyclo-hexanecarbonyl halides
AU2002324291A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU2002210855A1 (en) Synthesis of fused pyrrolecarboxamides